Articles

• Search by keyword
• Search by citation

12 result(s) for 'stefano alivernini' within Arthritis Research & Therapy

1. PSTPIP2 regulates synovial macrophages polarization and dynamics via ERβ in the joint microenvironment

   The cytoskeletal protein, PSTPIP2, is associated with inflammation and is predominantly expressed in macrophages. Previous data have shown that PSTPIP2 inhibits articular bone damage in arthritic rats. The aim...

   Authors: Yao Yao, Xiaoyu Cai, Meng Zhang, Xiao Zhang, Fujia Ren, Yan Zheng, Weidong Fei, Mengdan Zhao and Caihong Zheng

   Citation: Arthritis Research & Therapy 2022 24:247

   Content type: Research Published on: 2 November 2022

   • View Full Text
   • View PDF

   

2. Correction: Peripheral blood CD4^posCD25^posFoxP3^pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig

   Authors: Elisa Gremese, Barbara Tolusso, Luca Petricca, Clara Di Mario, Maria Rita Gigante, Gianfranco Ferraccioli and Stefano Alivernini

   Citation: Arthritis Research & Therapy 2022 24:177

   Content type: Correction Published on: 25 July 2022

   The original article was published in Arthritis Research & Therapy 2022 24:143

   • View Full Text
   • View PDF

3. Targeting pathogenic fibroblast-like synoviocyte subsets in rheumatoid arthritis

   Fibroblast-like synoviocytes (FLSs) play a central role in RA pathogenesis and are the main cellular component in the inflamed synovium of patients with rheumatoid arthritis (RA). FLSs are emerging as promisin...

   Authors: Hongyan Qian, Chaoqiong Deng, Shiju Chen, Xinwei Zhang, Yan He, Jingying Lan, Aodi Wang, Guixiu Shi and Yuan Liu

   Citation: Arthritis Research & Therapy 2024 26:103

   Content type: Review Published on: 23 May 2024

   • View Full Text
   • View PDF

4. ACR70-disease activity score remission achievement from switches between all the available biological agents in rheumatoid arthritis: a systematic review of the literature

   The aim of our analysis was to compare the gaining of a major response (disease activity score [DAS] remission or American College of Rheumatology 70% improvement criteria [ACR70]) by switching between all the...

   Authors: Stefano Alivernini, Antonella Laria, Elisa Gremese, Angelo Zoli and Gianfranco Ferraccioli

   Citation: Arthritis Research & Therapy 2009 11:R163

   Content type: Research article Published on: 3 November 2009

   • View Full Text
   • View PDF

5. Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission

   In this study, we assessed whether clinical and ultrasonography (US)-based remission could be used to select patients with rheumatoid arthritis (RA) eligible to taper and discontinue anti-TNF-α therapy after a...

   Authors: Stefano Alivernini, Giusy Peluso, Anna Laura Fedele, Barbara Tolusso, Elisa Gremese and Gianfranco Ferraccioli

   Citation: Arthritis Research & Therapy 2016 18:39

   Content type: Research article Published on: 3 February 2016

   • View Full Text
   • View PDF

6. Peripheral blood CD4^posCD25^posFoxP3^pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig

   Prognostic biomarkers of treatment response to distinct biologic disease-modifying anti-rheumatic drugs (b-DMARDs) are still lacking within the management of rheumatoid arthritis (RA).

   Authors: Elisa Gremese, Barbara Tolusso, Luca Petricca, Clara Di Mario, Maria Rita Gigante, Gianfranco Ferraccioli and Stefano Alivernini

   Citation: Arthritis Research & Therapy 2022 24:143

   Content type: Research Published on: 15 June 2022

   The Correction to this article has been published in Arthritis Research & Therapy 2022 24:177

   • View Full Text
   • View PDF

7. Correction to: Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts

   Following publication of the original article [1], it was brought to our attention that the AOSD Consensus Group was incorrectly tagged and therefore not searchable. The publishers apologize for this error.

   Authors: Serena Colafrancesco, Maria Manara, Alessandra Bortoluzzi, Teodora Serban, Gerolamo Bianchi, Luca Cantarini, Francesco Ciccia, Lorenzo Dagna, Marcello Govoni, Carlomaurizio Montecucco, Roberta Priori, Angelo Ravelli, Paolo Sfriso and Luigi Sinigaglia

   Citation: Arthritis Research & Therapy 2020 22:6

   Content type: Correction Published on: 9 January 2020

   The original article was published in Arthritis Research & Therapy 2019 21:275

   • View Full Text
   • View PDF

8. Correction to: Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups

   Following publication of the original article [1], the authors reported an error in the spelling of the ninth author’s name.

   Authors: Aurélie Najm, Benoît Le Goff, Carl Orr, Rogier Thurlings, Juan D. Cañete, Frances Humby, Stefano Alivernini, Antonio Manzo, Søren Andreas Just, Vasco C. Romão, Veit Krenn, Ulf Müller-Ladner, Olga Addimanda, Sander W. Tas, Maria Stoenoiu, Laurent Meric de Bellefon…

   Citation: Arthritis Research & Therapy 2018 20:282

   Content type: Correction Published on: 19 December 2018

   The original article was published in Arthritis Research & Therapy 2018 20:265

   • View Full Text
   • View PDF

9. Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups

   The aim of this global collaboration was to develop a consensual set of items for the analysis of synovial biopsies in clinical practice and translational research through the EULAR Synovitis Study Group (ESSG...

   Authors: Aurélie Najm, Benoît Le Goff, Carl Orr, Rogier Thurlings, Juan D. Cañete, Frances Humby, Stefano Alivernini, Antonio Manzo, Søren Andreas Just, Vasco C. Romão, Veit Krenn, Ulf Müller-Ladner, Olga Addimanda, Sander W. Tas, Maria Stoenoiu, Laurent Meric de Bellefon…

   Citation: Arthritis Research & Therapy 2018 20:265

   Content type: Research article Published on: 3 December 2018

   The Correction to this article has been published in Arthritis Research & Therapy 2018 20:282

   The Editorial to this article has been published in Arthritis Research & Therapy 2019 21:90

   • View Full Text
   • View PDF

10. Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis

    Differential diagnosis among psoriatic arthritis (PsA) and seronegative rheumatoid arthritis (Ab^neg RA) can be challenging particularly in the clinical setting of peripheral phenotype and autoantibodies seronegat...

    Authors: Stefano Alivernini, Dario Bruno, Barbara Tolusso, Laura Bui, Luca Petricca, Maria Rita Gigante, Domenico Birra, Anna Laura Fedele, Giusy Peluso, Francesco Federico, Gianfranco Ferraccioli and Elisa Gremese

    Citation: Arthritis Research & Therapy 2019 21:116

    Content type: Research article Published on: 9 May 2019

    • View Full Text
    • View PDF

11. Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression

    The purpose of this study was to investigate the frequency and the distribution of inflammatory cell infiltrate in two sets of cutaneous biopsies derived from clinically affected and unaffected skin in patient...

    Authors: Silvia Bosello, Cristiana Angelucci, Gina Lama, Stefano Alivernini, Gabriella Proietti, Barbara Tolusso, Gigliola Sica, Elisa Gremese and Gianfranco Ferraccioli

    Citation: Arthritis Research & Therapy 2018 20:75

    Content type: Research article Published on: 18 April 2018

    • View Full Text
    • View PDF

12. Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts

    Adult-onset Still’s disease (AOSD) is a rare inflammatory condition characterized by fever, rash, and arthritis. Because of its rarity, clinical trials are inherently small and often uncontrolled. Our objectiv...

    Authors: Serena Colafrancesco, Maria Manara, Alessandra Bortoluzzi, Teodora Serban, Gerolamo Bianchi, Luca Cantarini, Francesco Ciccia, Lorenzo Dagna, Marcello Govoni, Carlomaurizio Montecucco, Roberta Priori, Angelo Ravelli, Paolo Sfriso and Luigi Sinigaglia

    Citation: Arthritis Research & Therapy 2019 21:275

    Content type: Research article Published on: 11 December 2019

    The Correction to this article has been published in Arthritis Research & Therapy 2020 22:6

    • View Full Text
    • View PDF